HHS awards Moderna $176 million for mRNA bird flu vaccine

Published July 2, 2024 1:44pm ET



The Department of Health and Human Services announced on Tuesday that Moderna will be given $176 million for its mRNA bird flu vaccine as part of the Biden administration’s preparedness efforts in the event of a widespread outbreak of the infection among humans.

“We have successfully taken lessons learned during the COVID-19 pandemic and used them to better prepare for future public health crises,” HHS Secretary Xavier Becerra said in a press statement on Tuesday. “As part of that, we continue to develop new vaccines and other tools to help address influenza and bolster our pandemic response capabilities.”

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.